title: [Update on current care guideline: dyslipidaemias].
abstract: The updated guideline on the treatment of dyslipidaemias is in concordance with European guidelines on cardiovascular disease prevention. Treatment of dyslipidaemia aims to reduce the risk of atherosclerotic vascular diseases. Therapeutic targets for LDL cholesterol, determined by risk assessment, range from concentration < 1.8 mmol/l (very high risk), < 2.5 mmol/l (high risk) to < 3.0 mmol/l (moderate or low risk). Lifestyle (diet, including replacement of saturated with unsaturated fat, physical activity, nonsmoking, stress management) is the cornerstone of treatment. Drug therapy, mainly statins, is considered when risk-stratified LDL targets are not reached otherwise.
mesh_terms: D008078:Cholesterol, LDL / Q000097:blood; D050171:Dyslipidemias / Q000628:therapy*; D005060:Europe; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008019:Life Style; D017410:Practice Guidelines as Topic; D018570:Risk Assessment
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors